Cardiac and Cerebrovascular Protection: The Role of Salvia Miltiorrhiza and Ligustrazine Injection

Salvia Miltiorrhiza and Ligustrazine Injection is a traditional Chinese medicine formulation widely recognized for its ability to promote blood circulation and remove blood stasis. It is commonly prescribed for the prevention of thrombosis and the management of cardiovascular conditions such as angina pectoris associated with coronary heart disease. By improving circulation and reducing clot formation, this injection helps lower the risk of major cardiovascular events.

Application in Cardiovascular and Cerebrovascular Diseases

One of the key benefits of this injection is its dual protective effect on both the heart and brain. In addition to cardiovascular therapy, it is also used in treating cerebrovascular disorders including cerebral thrombosis, cerebral infarction, and ischemic stroke. These conditions often result from impaired blood flow, and the injection helps restore circulation, potentially minimizing tissue damage and supporting neurological recovery.

Recommended Usage and Duration

While this medication can be effective, it is not intended for long-term use, especially among elderly patients who may be more susceptible to complications. Clinical guidelines suggest that it is most beneficial when administered during the acute phase of a cardiovascular or cerebrovascular event—typically within the first month following the incident.

Medical Supervision is Essential

Currently, there is insufficient scientific evidence to support the routine long-term use of traditional Chinese injections like Salvia Miltiorrhiza and Ligustrazine for the prevention of heart or brain-related vascular events. Therefore, it's crucial for patients to follow medical advice and not to self-medicate. Only under the supervision of a qualified healthcare provider should this injection be considered, ensuring safe and effective treatment tailored to the individual's condition.